Related Experiment Video
Updated: Jul 7, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute liver failure in pregnancy: an overview
1Stanley Medical College, Chennai, India. drjayanthi35@yahoo.co.in
Minerva Gastroenterologica E Dietologica
|February 27, 2008
Summary
Acute liver failure in pregnancy poses diagnostic and management challenges. Prompt recognition and delivery are crucial for successful outcomes, especially with viral hepatitis E and HELLP syndrome.
Area of Science:
- Hepatology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Acute liver failure (ALF) in pregnancy presents significant diagnostic and management challenges.
- Acute viral hepatitis is a common cause of jaundice, with Hepatitis E (HEV) posing high mortality risks in endemic areas.
- Pregnancy-specific conditions like HELLP syndrome and acute fatty liver of pregnancy also increase maternal and fetal mortality.
Purpose of the Study:
- To review the current understanding of acute liver failure in pregnancy.
- To discuss the common causes and management strategies for ALF during pregnancy.
- To emphasize the importance of early diagnosis and intervention.
Main Methods:
- This is a review article.
- It synthesizes existing literature on ALF in pregnancy.
- Focuses on common etiologies and therapeutic approaches.
Main Results:
- Hepatitis E infection significantly increases maternal and fetal mortality in pregnancy.
- Pregnancy-specific ALF conditions require early recognition and intervention.
- Prompt delivery is a key treatment, often leading to rapid maternal recovery.
Conclusions:
- Early diagnosis and prompt management, including delivery, are critical for improving outcomes in ALF during pregnancy.
- Understanding the specific causes of ALF in pregnancy, such as HEV and HELLP syndrome, guides effective treatment.
- Successful management hinges on a multidisciplinary approach to protect both mother and fetus.
More Related Videos
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...